Department of Cardiology, Marmara University Faculty of Medicine, Istanbul, Turkey.
Eur Rev Med Pharmacol Sci. 2013 Dec;17(24):3323-8.
Subclinical hypothyroidism (SH) is an asymptomatic condition defined by increased serum thyroid-stimulating hormone (TSH) with normal free thyroid hormone levels. Heart is a major target organ for thyroid hormone action. The aim of this study was to evaluate cardiac functions in patients with SH by speckle tracking imaging.
We included 23 consecutive patients with untreated SH (Group A; 7 male, mean age: 40.9±1.6 years) and 21 patients with treated SH (Group B; 6 male, mean age: 40.2±2.1 years). The control group included 25 healthy volunteers (8 male, mean age: 39.9±2.8 years). Left ventricular (LV) functions were assessed with speckle tracking imaging.
Age and sex distributions were similar among the groups. Mean serum TSH and free T4 levels were 11.7±2.9 µIU/mL, 1.16±0.06 ng/dL for group A; 2.6±0.3 µIU/mL, 1.35±0.09 ng/dL for group B; 1.4±0.3 µIU/mL, 1.31±0.09 ng/dL for controls, respectively (p = 0.001, p = 0.122). The untreated SH patients had significantly lower LV strain and strain rate values compared to controls. The treated SH patients had higher LV strain and strain rate values compared to untreated SH patients although the difference was not statistically significant. The treated SH patients had lower LV strain and strain rate values compared to controls but the difference was not statistically significant.
Untreated SH is associated with impairment in LV longitudinal myocardial function. Speckle tracking echocardiography appears to be useful both for early detection of LV impairment in patients with SH and documentation of improvement in myocardial deformation parameters with treatment.
亚临床甲状腺功能减退症(SH)是一种无症状的疾病,其定义为血清促甲状腺激素(TSH)升高而游离甲状腺激素水平正常。心脏是甲状腺激素作用的主要靶器官。本研究旨在通过斑点追踪成像评估 SH 患者的心脏功能。
我们纳入了 23 例未经治疗的 SH 患者(A 组;7 例男性,平均年龄:40.9±1.6 岁)和 21 例接受治疗的 SH 患者(B 组;6 例男性,平均年龄:40.2±2.1 岁)。对照组包括 25 名健康志愿者(8 名男性,平均年龄:39.9±2.8 岁)。采用斑点追踪成像评估左心室(LV)功能。
三组间年龄和性别分布相似。A 组患者的平均血清 TSH 和游离 T4 水平分别为 11.7±2.9 µIU/mL、1.16±0.06 ng/dL;B 组分别为 2.6±0.3 µIU/mL、1.35±0.09 ng/dL;对照组分别为 1.4±0.3 µIU/mL、1.31±0.09 ng/dL(p=0.001,p=0.122)。未经治疗的 SH 患者的 LV 应变和应变率值明显低于对照组。与未经治疗的 SH 患者相比,接受治疗的 SH 患者的 LV 应变和应变率值更高,但差异无统计学意义。与对照组相比,接受治疗的 SH 患者的 LV 应变和应变率值较低,但差异无统计学意义。
未经治疗的 SH 与 LV 纵向心肌功能障碍有关。斑点追踪超声心动图似乎对早期发现 SH 患者的 LV 损害以及记录心肌变形参数随治疗的改善均有用。